| abstract |
Pharmaceutical compounds and compositions for injectable use in the treatment of thromboxane A 2 mediating diseases, comprising a pharmaceutical carrier and a pharmacologically effective amount of a compound of the formula: ##STR1## wherein R 1 is carboxyl or 5-tetrazolyl; R 2 is hydrogen, methyl, hydroxy, chloro, or bromo; or a pharmaceutically acceptable ester or salt thereof, together with one or more non-toxic pharmaceutically acceptable carriers; and methods for treating thromboxane A 2 mediating diseases. |